TARGETING THE HOX TRANSCRIPTION FACTORS AND CD71 IN MULTIPLE MYELOMA

被引：0
|
作者：
Daniels, Tracy R. [1 ]
Neacato, Isabel I. [1 ]
Rodriguez, Jose A. [1 ,2 ]
Pandha, Hardev S. [3 ]
Morgan, Richard [3 ]
Penichet, Manuel L. [1 ,2 ,4 ,5 ]
机构：
[1] Univ Calif Los Angeles, Dept Surg, Div Surg Oncol, Los Angeles, CA 90024 USA
[2] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA
[3] Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England
[4] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA
[5] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA
来源：
ANTICANCER RESEARCH | 2014年 / 34卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
494
引用
收藏
页码：6107 / 6108
页数：2
相关论文
共 50 条
  • [31] Alternatively spliced transcripts of the human transferrin receptor (CD71) gene
    Woith, W
    Herrmann, M
    Lottspeich, F
    Nuesslein, I
    Kalden, JR
    Manger, B
    FASEB JOURNAL, 1996, 10 (06): : 231 - 231
  • [32] Kinase Regulation of HOX Transcription Factors
    Primon, Monika
    Hunter, Keith D.
    Pandha, Hardev S.
    Morgan, Richard
    CANCERS, 2019, 11 (04):
  • [33] Molecular dynamics of targeting CD38 in multiple myeloma
    Malavasi, Fabio
    Faini, Angelo C.
    Morandi, Fabio
    Castella, Barbara
    Incarnato, Danny
    Oliviero, Salvatore
    Horenstein, Alberto L.
    Massaia, Massimo
    van de Donk, Niels W. C. J.
    Richardson, Paul G.
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (03) : 581 - 591
  • [34] Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma
    Lokhorst, H. M.
    Plesner, T.
    Laubach, J. P.
    Nahi, H.
    Gimsing, P.
    Hansson, M.
    Minnema, M. C.
    Lassen, U.
    Krejcik, J.
    Palumbo, A.
    van de Donk, N. W. C. J.
    Ahmadi, T.
    Khan, I.
    Uhlar, C. M.
    Wang, J.
    Sasser, A. K.
    Losic, N.
    Lisby, S.
    Basse, L.
    Brun, N.
    Richardson, P. G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (13): : 1207 - 1219
  • [35] Blockade of CD71 prolongs pancreatic islet graft survival.
    Rastellini, C
    Braun, M
    Li, XM
    Blanchard, J
    Milewski, S
    Brown, M
    Cicalese, L
    Benedetti, E
    TRANSPLANTATION, 2000, 69 (08) : S195 - S195
  • [36] Targeting CD47 as a Novel Immunotherapy for Multiple Myeloma
    Sun, Jennifer
    Muz, Barbara
    Alhallak, Kinan
    Markovic, Matea
    Gurley, Shannon
    Wang, Zhe
    Guenthner, Nicole
    Wasden, Katherine
    Fiala, Mark
    King, Justin
    Kohnen, Daniel
    Salama, Noha Nabil
    Vij, Ravi
    Azab, Abdel Kareem
    CANCERS, 2020, 12 (02)
  • [37] Artesunate exerts specific cytotoxicity in retinoblastoma cells via CD71
    Zhao, Fei
    Wang, Han
    Kunda, Patricilia
    Chen, Xuemei
    Liu, Qiu-Ling
    Liu, Tao
    ONCOLOGY REPORTS, 2013, 30 (03) : 1473 - 1482
  • [38] Prognostic value of CD71 expression in mantle cell lymphoma.
    Lanson, B
    Drenou, B
    Gueret, P
    Amiot, L
    Bernard, M
    Dauriac, C
    LePrise, PY
    Fauchet, R
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 401 - 401
  • [39] Enhanced expression of the CD71 mesangial IgA1 receptor in Berger disease and Henoch-Schonlein nephritis: Association between CD71 expression and IgA deposits
    Haddad, E
    Moura, IC
    Arcos-Fajardo, M
    Macher, MA
    Baudouin, V
    Alberti, C
    Loirat, C
    Monteiro, RC
    Peuchmaur, M
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (02): : 327 - 337
  • [40] 胃癌患者外周血CD71/44、CD133/3的表达
    李午
    中国卫生检验杂志, 2013, 23 (06) : 1505 - 1506
12345